2012 European guideline for the management of anogenital warts
- 12 March 2012
- journal article
- review article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 27 (3), e263-e270
- https://doi.org/10.1111/j.1468-3083.2012.04493.x
Abstract
Although new HPV vaccines have been developed and are in the process of implementation, anogenital warts remain a very frequent problem in clinical practice. We wished to update previously published European guidelines for the management of anogenital warts. We performed a systematic review of randomized controlled trials for anogenital warts. The primary data were analyzed and collated, and the findings were formulated within the structure of a clinical guideline. The IUSTI Europe Editorial Board reviewed the draft guideline which was also posted on the web for comments which we incorporated into the final version of the guideline. The data confirm that only surgical therapies have primary clearance rates approaching 100%. Recurrences, including new lesions at previously treated or new sites, occur after all therapies, and rates are often 20-30% or more. All therapies are associated with local skin reactions including itching, burning, erosions and pain. Physicians treating patients with genital warts should develop their own treatment algorithms which include local practice and recommendations. Such patient level management protocols should incorporate medical review of cases at least every 4 weeks, with switching of treatments if an inadequate response is observed. First episode patients should be offered sexually transmitted disease screening. Management should include partner notification and health promotion.Keywords
This publication has 48 references indexed in Scilit:
- Efficacy and Safety of Imiquimod Versus Podophyllotoxin in the Treatment of Anogenital WartsSexually Transmitted Diseases, 2011
- Interferon for the treatment of genital warts: a systematic reviewBMC Infectious Diseases, 2009
- Earlier Eradication of Intra-Anal Warts with Argon Plasma Coagulator Combined with Imiquimod Cream Compared with Argon Plasma Coagulator Alone: A Prospective, Randomized TrialDiseases of the Colon & Rectum, 2007
- The use of topical 5% imiquimod during pregnancy: A case seriesReproductive Toxicology, 2006
- Risk factors for the acquisition of genital warts: are condoms protective?Sexually Transmitted Infections, 1999
- Topical treatment of genital warts in men, an open study of podophyllotoxin cream compared with solution.Sexually Transmitted Infections, 1995
- Quercetin and kaempherol: an argument against the use of podophyllin?Sexually Transmitted Infections, 1995
- Clinical efficacy of Condyline (0.5% podophyllotoxin) solution and cream versus podophyllin in the treatment of external condylomata acuminataJournal of Dermatological Treatment, 1990
- Podophyllotoxin 0.5% v podophyllin 20% to treat penile warts.Sexually Transmitted Infections, 1988
- Natural history of genital warts.Sexually Transmitted Infections, 1971